Cytokinetics, Incorporated · NASDAQ:CYTK

Malik Fady Ibraham sold 3,500 Cytokinetics, Incorporated shares (Form 4)

Traded May 5, 2026 · Filed May 5, 2026

On May 5, 2026, Malik Fady Ibraham (EVP Research & Development) sold 3,500 Cytokinetics, Incorporated shares at US$77.37 for US$271K under a trading plan, leaving 153,902 shares. Filed May 5, 2026 (Form 4).

Sold
3,500 shares
Price
US$77.37
Value
US$271K
Holding after
153,902 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP Research & Development

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 5, 2026Common StockOption exercise3,500US$7.80157,402Direct
May 5, 2026Common StockSale3,500US$77.37153,902Direct

Source

View original at SEC

Related